Keyphrases
Head-and-neck Cancer
100%
Electrochemotherapy
100%
Complete Response
20%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
20%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
20%
Overall Response Rate
20%
Objective Response
20%
Tumor Response
20%
Local Recurrence
20%
General Anesthesia
20%
Pain Level
20%
Phase II Clinical Trial
20%
Curative Treatment
20%
Partial Response
20%
Cutaneous Tumors
20%
Quality of Life Questionnaire
20%
Bleeding Episodes
20%
Treatment Options
20%
Disease Progression
20%
Positron Emission Tomography
20%
Serious Adverse Events
20%
Pain Score
20%
Computed Tomography
20%
Medicine and Dentistry
Head and Neck Cancer
100%
Electrochemotherapy
100%
Recurrent Disease
40%
Neoplasm
20%
Fluorodeoxyglucose
20%
Head and Neck Carcinoma
20%
Magnetic Resonance Imaging
20%
Quality of Life
20%
General Anesthesia
20%
Biopsy Technique
20%
Adverse Event
20%
positron emission tomographic scan
20%
Skin Tumor
20%
Clinical Trial
20%
Disease Exacerbation
20%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
100%
Recurrent Disease
66%
Skin Tumor
33%
Adverse Event
33%
Head and Neck Carcinoma
33%
Neoplasm
33%
Clinical Trial
33%
Fluorodeoxyglucose
33%
Disease Exacerbation
33%